In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

EHJ – Cardiovascular Pharmacotherapy

Specific Focus on Clinical Cardiovascular Pharmacology


The European Heart Journal – Cardiovascular Pharmacotherapy (EHJ-CVP) is the official journal of the European Society of Cardiology and the ESC Working Group on Cardiovascular Pharmacotherapy. The journal reports on the interpretation and integration of new scientific developments  to improve the pharmacological treatment of patients with cardiovascular disease.

It publishes original articles on clinical research, with new and established drugs and methods, as well as meta-analysis and topical reviews.


Fast Facts

  • Editor-in-chief: Stefan Agewall FESC, NO
  • Current volume: 6 (year 2020)
  • Issues per subscription: 4
  • Impact Factor 2018: 6.723
Updates on latest articles

Updates on latest articles


Receive the table of contents in your mailbox.

Track topics and authors  important to you and receive articles in your mailbox.

For Authors

Before being published, all manuscripts go through double-blind, peer review by experienced international experts.

Most recent articles from EHJ-CVP

16 Mar 2020
Lipids and antithrombotic treatment
Author(s):Agewall S.
13 Jan 2020
ESC Guidelines revisited
Author(s):Drexel H, Milbradt S.
14 Jan 2020
Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study
Author(s):Rutherford O, Jonasson C, Ghanima W, et al.
24 Dec 2019
ESC position paper on statins adherence and implementation of new lipid-lowering medications: barriers to be overcome
Author(s):Drexel H, Coats A, Spoletini I, et al.